亚太药业：拟5000万元设立全资子公司

Core Viewpoint - Asia-Pacific Pharmaceutical (002370.SZ) announced the establishment of a wholly-owned subsidiary, Zhejiang Yatai Lizhong Investment Holding Co., Ltd., with a capital investment of 50 million yuan to enhance its industrial development layout [1] Group 1 - The company plans to use its own funds amounting to 50 million yuan for the establishment of the new subsidiary [1] - The name of the subsidiary is provisional and will be finalized upon approval from the relevant registration authority [1]